TY - JOUR AU - Supiot, Stéphane AU - Rousseau, Caroline PY - 2019 TI - Oligometastatic prostate cancer: is it worth targeting the tip of the iceberg? JF - Translational Cancer Research; Vol 8, Supplement 2 (March 28, 2019): Translational Cancer Research Y2 - 2019 KW - N2 - Until recently, the only routinely available imaging techniques of prostate cancer were computed tomography (CT) scan ± contrast, magnetic resonance imaging (MRI) and a standard bone scan. The increasing use of modern imaging techniques such as positron emission tomography-computed tomography (PET-CT) with tumour-specific radiotracers [Choline, Fluciclovine or prostate-specific membrane antigen (PSMA) ligand], and, increasingly, whole-body MRI with diffusion-weighted imaging (WB MRI-DWI), means that oligometastases in prostate cancer are commonly discovered before any radical treatment or once the prostate specific antigen (PSA) has risen following radical treatment. UR - https://tcr.amegroups.org/article/view/26599